These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18717603)

  • 1. EGFR inhibitor-associated acneiform folliculitis: assessment and management.
    Duvic M
    Am J Clin Dermatol; 2008; 9(5):285-94. PubMed ID: 18717603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytomenadione pre-treatment in EGFR inhibitor-induced folliculitis.
    Tomková H; Pospíšková M; Zábojníková M; Kohoutek M; Serclová M; Gharibyar M; Sternberský J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):514-9. PubMed ID: 22035385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous side effects of EGF receptor inhibitors].
    Nassar D; Soutou B; Aractingi S
    Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
    Cholongitas E; Pipili C; Ioannidou D
    J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab-induced acne.
    Molinari E; De Quatrebarbes J; André T; Aractingi S
    Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Requena C; Llombart B; Sanmartín O
    Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
    Lenz HJ
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):5-13. PubMed ID: 16736978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne.
    Yu HJ; Lee SK; Son SJ; Kim YS; Yang HY; Kim JH
    Int J Dermatol; 1998 Oct; 37(10):772-7. PubMed ID: 9802688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
    Shin JU; Park JH; Cho BC; Lee JH
    Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
    Gencoglan G; Ceylan C
    Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for acne.
    James KA; Burkhart CN; Morrell DS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):649-59. PubMed ID: 19772370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tufted hair folliculitis in a woman treated with trastuzumab.
    Rosman IS; Anadkat MJ
    Target Oncol; 2010 Dec; 5(4):295-6. PubMed ID: 20949375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections.
    Braden RL; Anadkat MJ
    Support Care Cancer; 2016 Sep; 24(9):3943-50. PubMed ID: 27117557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of the amounts and expressions of epidermal growth factor, epidermal growth factor receptor, and epidermal growth factor receptor gene polymorphisms in acne vulgaris.
    Aydingoz IE; Tukenmez Demirci G; Agirbasli D; Oz-Arslan D; Yenmis G
    J Cosmet Dermatol; 2021 Jan; 20(1):346-351. PubMed ID: 32421896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skin signs associated with epidermal growth factor inhibitors].
    Hannoud S; Rixe O; Bloch J; Le Pelletier F; Lebrun-Vignes B; Doarika A; Khayat D; Chosidow O
    Ann Dermatol Venereol; 2006 Mar; 133(3):239-42. PubMed ID: 16800173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paroxysmal iatrogenic acne and the epidermal growth factor receptor inhibitors (EGFR)].
    Piérard-Franchimont C; Blaise G; Paquet P; Quatresooz R; Rorive A; Piérard GE
    Rev Med Liege; 2007 Jan; 62(1):11-4. PubMed ID: 17343123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous lesions due to inhibition of epidermal growth factor receptor].
    Bierhoff E; Seifert HW; Dirschka T
    Pathologe; 2006 Feb; 27(1):53-6. PubMed ID: 16362261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gefitinib-associated folliculitis.
    Matheis P; Socinski MA; Burkhart C; Warren S; Thomas NE
    J Am Acad Dermatol; 2006 Oct; 55(4):710-3. PubMed ID: 17010757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
    Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
    Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
    Ocvirk J; Cencelj S
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.